lipoxin a4 has been researched along with Acute Lung Injury in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (5.56) | 29.6817 |
| 2010's | 14 (77.78) | 24.3611 |
| 2020's | 3 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Z; Tong, K; Wang, M; Wen, Z | 1 |
| Chen, B; Ni, X; Pan, R; Shi, K; Shi, Z; Sun, H; Xiang, Y; Ye, W; Yu, D; Zhang, F; Zhang, Q; Zhang, Z; Zheng, C; Zhou, M | 1 |
| Hong, Y; Li, Y; Ma, Z; Wang, N; Wang, Y; Yuan, Y; Zhao, M; Zhong, Z | 1 |
| Croze, RH; Fang, X; Gotts, JE; Matthay, MA; Siegel, ER | 1 |
| Afonyushkin, T; Berdyshev, E; Birukov, KG; Birukova, AA; Bochkov, VN; Ke, Y; Meng, F; Oskolkova, O; Sarich, N; Tian, Y; Wang, JM; Zebda, N | 1 |
| Lin, HJ; Liu, ZL; Zhang, JZ; Zhang, YX; Zhang, ZJ | 1 |
| Chen, QF; Hao, H; Huang, YH; Kuang, XD; Yuan, QF; Zhang, T; Zhou, XY | 1 |
| Chang, Y; Liu, Z; Qu, M; Yang, Q | 1 |
| Chen, B; Shi, Z; Sun, H; Ye, W; Yu, D; Yu, H; Zhang, F; Zhang, J; Zhou, M | 1 |
| da Silva, RF; da-Palma-Cruz, M; de Oliveira, APL; Grabulosa, CC; Lino-Dos-Santos-Franco, A; Monteiro, D; Rehim, HMMA | 1 |
| Chen, F; He, Q; Huang, CJ; Jin, SW; Li, R; Lian, QQ; Smith, FG; Wang, Q; Wu, DR; Yang, Y; Ying, BY; Zheng, SX; Zheng, X | 1 |
| Cheng, Y; Jin, SW; Li, WJ; Lian, QQ; Liu, YJ; Qi, W; Smith, FG; Wu, DR; Yang, L; Yang, Y; Zheng, X | 1 |
| Andersson, R; Chen, B; Kong, H; Lv, C; Lv, W; Sun, H; Xie, J; Xu, D; Yang, Y; Yu, S; Zhou, M | 1 |
| Bins, A; Headley, M; Krummel, MF; Looney, MR; Mallavia, B; Ortiz-Muñoz, G | 1 |
| Zimring, JC | 1 |
| Abbott, J; Cheng, L; Colby, JK; Fang, X; Lee, JW; Levy, BD; Matthay, MA | 1 |
| Cheng, X; Gao, H; He, S; Li, Y; Miao, S; Peng, W; Wu, P; Yuan, J; Zhang, J | 1 |
| El Kebir, D; Filep, JG; József, L; Pan, W; Petasis, NA; Serhan, CN; Wang, L | 1 |
18 other study(ies) available for lipoxin a4 and Acute Lung Injury
| Article | Year |
|---|---|
Mechanisms of 15-Epi-LXA4-Mediated HO-1 in Cytoprotection Following Inflammatory Injury.
Topics: Acute Disease; Acute Lung Injury; Cytoprotection; Endothelial Cells; Heme Oxygenase-1; Humans; Kelch-Like ECH-Associated Protein 1; NF-E2-Related Factor 2; Oxidative Stress; Pancreatitis; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Tumor Necrosis Factor-alpha | 2023 |
Lipoxin A4 Ameliorates Acute Pancreatitis-Associated Acute Lung Injury through the Antioxidative and Anti-Inflammatory Effects of the Nrf2 Pathway.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents; Antioxidants; Humans; Lipoxins; Mice; Mice, Knockout; NF-E2-Related Factor 2; Pancreatitis; Signal Transduction | 2019 |
Lipoxin A4 protects against paraquat‑induced acute lung injury by inhibiting the TLR4/MyD88‑mediated activation of the NF‑κB and PI3K/AKT pathways.
Topics: Acute Lung Injury; Animals; Cytokines; Lipoxins; Male; Malondialdehyde; Mice; Myeloid Differentiation Factor 88; NF-kappa B; Paraquat; Phosphatidylinositol 3-Kinases; Protective Agents; Proto-Oncogene Proteins c-akt; Pulmonary Edema; Rats, Sprague-Dawley; RAW 264.7 Cells; Superoxide Dismutase; Toll-Like Receptor 4 | 2021 |
Inhibition of the lipoxin A4 and resolvin D1 receptor impairs host response to acute lung injury caused by pneumococcal pneumonia in mice.
Topics: Acute Lung Injury; Animals; Docosahexaenoic Acids; Humans; Inflammation; Lipoxins; Lung; Mice; Permeability; Pneumonia, Pneumococcal; Receptors, Lipoxin; Respiratory Distress Syndrome | 2021 |
Anti-Inflammatory Effects of OxPAPC Involve Endothelial Cell-Mediated Generation of LXA4.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cells, Cultured; Endothelial Cells; Humans; Lipoxins; Mice; Mice, Inbred C57BL; Mice, Knockout; Phosphatidylcholines; Treatment Outcome | 2017 |
Lipoxin A4 Ameliorates Lipopolysaccharide-Induced A549 Cell Injury through Upregulation of N-myc Downstream-Regulated Gene-1.
Topics: A549 Cells; Acute Lung Injury; Cell Cycle Proteins; Cell Line; Epithelial Sodium Channels; Humans; Intracellular Signaling Peptides and Proteins; Lipopolysaccharides; Lipoxins; Signal Transduction | 2018 |
Lipoxin A
Topics: Acute Lung Injury; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme 2; Animals; Cell Line, Tumor; Disease Models, Animal; Humans; Imidazoles; Leucine; Lipopolysaccharides; Lipoxins; Male; Mice; NF-kappa B; Peptide Fragments; Peptidyl-Dipeptidase A; Proto-Oncogene Mas; Proto-Oncogene Proteins; Receptors, G-Protein-Coupled; Signal Transduction | 2018 |
Lipoxin A4 ameliorates renal ischaemia-reperfusion-induced acute lung injury in rats.
Topics: Acute Lung Injury; Animals; Bronchoalveolar Lavage Fluid; Cytoprotection; Gene Expression Regulation; HMGB1 Protein; Inflammation Mediators; Kidney; Lipoxins; Male; Mitogen-Activated Protein Kinases; NF-kappa B; Peroxidase; Phosphorylation; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Toll-Like Receptor 4 | 2019 |
LipoxinA4 attenuates acute pancreatitis-associated acute lung injury by regulating AQP-5 and MMP-9 expression, anti-apoptosis and PKC/SSeCKS-mediated F-actin activation.
Topics: A Kinase Anchor Proteins; Actins; Acute Disease; Acute Lung Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aquaporin 5; Cell Cycle Proteins; Cells, Cultured; Gene Expression; Humans; Lipoxins; Matrix Metalloproteinase 9; Mice, Inbred BALB C; Pancreatitis; Protein Kinase C; Signal Transduction | 2018 |
Photobiomodulation modulates the resolution of inflammation during acute lung injury induced by sepsis.
Topics: Acute Lung Injury; Animals; Bone Marrow; Bronchoalveolar Lavage; Cell Movement; Cholinergic Agents; Cytokines; Eicosapentaenoic Acid; Inflammation; Lipopolysaccharides; Lipoxins; Low-Level Light Therapy; Lung; Male; Mice, Inbred BALB C; Muscle Contraction; Muscle, Smooth; Sepsis | 2019 |
Lipoxin A(4) activates alveolar epithelial sodium channel, Na,K-ATPase, and increases alveolar fluid clearance.
Topics: Acute Lung Injury; Alveolar Epithelial Cells; Animals; Cells, Cultured; Cyclic AMP; Cyclic GMP; Epithelial Sodium Channel Agonists; Epithelial Sodium Channel Blockers; Epithelial Sodium Channels; Gene Expression; Heptanoic Acids; Lipopolysaccharides; Lipoxins; Male; Mucociliary Clearance; Oligopeptides; Peroxidase; Pulmonary Alveoli; Rats; Rats, Sprague-Dawley; Sodium-Potassium-Exchanging ATPase; Tumor Necrosis Factor-alpha | 2013 |
Contribution of CFTR to alveolar fluid clearance by lipoxin A4 via PI3K/Akt pathway in LPS-induced acute lung injury.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Cells, Cultured; Cystic Fibrosis Transmembrane Conductance Regulator; Fluorescent Antibody Technique; Immunohistochemistry; Interleukin-6; Lipopolysaccharides; Lipoxins; Male; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Signal Transduction; Tumor Necrosis Factor-alpha | 2013 |
Lipoxin A4 attenuation of endothelial inflammation response mimicking pancreatitis-induced lung injury.
Topics: Acute Lung Injury; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Cells, Cultured; Chemokine CCL8; E-Selectin; eIF-2 Kinase; Endothelium, Vascular; Humans; Inflammation; Intercellular Adhesion Molecule-1; Interleukin-6; Lipoxins; Lung; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Pancreatitis; Real-Time Polymerase Chain Reaction; Tumor Necrosis Factor-alpha | 2013 |
Aspirin-triggered 15-epi-lipoxin A4 regulates neutrophil-platelet aggregation and attenuates acute lung injury in mice.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blood Platelets; Bronchoalveolar Lavage Fluid; Cell Communication; Leukocyte Count; Lipopolysaccharides; Lipoxins; Luminescent Proteins; Lung; Male; Mice, Inbred BALB C; Mice, Knockout; Mice, Transgenic; Microscopy, Fluorescence; Neutrophils; Oligopeptides; Platelet Aggregation; Receptors, Formyl Peptide; Survival Analysis; Transfusion Reaction | 2014 |
The fat and the skinny on acute lung injury.
Topics: Acute Lung Injury; Animals; Aspirin; Lipoxins; Male; Neutrophils; Platelet Aggregation | 2014 |
Human Mesenchymal Stem (Stromal) Cells Promote the Resolution of Acute Lung Injury in Part through Lipoxin A4.
Topics: Acute Lung Injury; Adult; Animals; Cells, Cultured; Chemokine CXCL2; Coculture Techniques; Epithelial Cells; Humans; Immunotherapy; Lipopolysaccharides; Lipoxins; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Mice; Mice, Inbred C57BL; Oligopeptides; Receptors, Formyl Peptide; Receptors, Lipoxin; Respiratory Distress Syndrome; Respiratory Mucosa; Tumor Necrosis Factor-alpha | 2015 |
Lipoxin A4 attenuates LPS-induced mouse acute lung injury via Nrf2-mediated E-cadherin expression in airway epithelial cells.
Topics: Acute Lung Injury; Animals; Cadherins; Cell Line; Epithelial Cells; Gene Expression Regulation; Humans; Inflammation; Lipopolysaccharides; Lipoxins; Lung; Mice; NF-E2-Related Factor 2 | 2016 |
15-epi-lipoxin A4 inhibits myeloperoxidase signaling and enhances resolution of acute lung injury.
Topics: Acute Lung Injury; Animals; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Bronchoalveolar Lavage Fluid; Caspase 3; CD18 Antigens; Female; Humans; Interleukin-6; Leukocyte Count; Lipoxins; Lung; Mice; Mice, Inbred BALB C; Neutrophils; Peroxidase; Signal Transduction | 2009 |